Feedback (LSE:FDBK) Insider Ownership : 7.98 % (As of Jun. 21, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Feedback Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Feedback's insider ownership is 7.98%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Feedback's Institutional Ownership is 32.80%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Feedback's Float Percentage Of Total Shares Outstanding is 0.00%.

Feedback Insider Ownership Historical Data

The historical data trend for Feedback's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feedback Insider Ownership Chart

Feedback Historical Data

The historical data trend for Feedback can be seen below:

	2021-12-31	2022-01-31	2022-02-28	2022-03-31	2022-04-30	2022-05-31	2022-06-30	2022-07-31	2022-08-31	2022-09-30
Insider Ownership	7.98	7.98	7.98	7.98	7.98	7.98	7.98	7.98	7.98	7.98

Feedback Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Feedback (LSE:FDBK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT

Website

https://www.fbkmed.com

Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.

Feedback (LSE:FDBK) Headlines

No Headlines